|     home    |     search     |     content     |     mail     |     login     |

study information

date of publication1-nov-1999
journalJ Virol 1999 Nov;73(11):9153-60
titleLongitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes: correlation with disease progression.
title in Dutch
resp. centreCLB
designFew studies have examined longitudinal changes in human immunodeficiency virus type 1 (HIV)-specific cytotoxic T lymphocytes (CTL). To more closely define the natural history of HIV-specific CTL, we used HLA-peptide tetrameric complexes to study the longitudinal CD8(+) T-cell response evolution in 16 A*0201-positive untreated individuals followed clinically for up to 14 years. As early as 1 to 2 years after seroconversion, we found a significant association between high frequencies of A*0201-restricted p17(Gag/Pol) tetramer-binding cells and slower disease progression (P < 0.01). We observed that responses could remain stable over many months, but any longitudinal changes that occurred were typically accompanied by reciprocal changes in RNA viral load. Phenotypic analysis with markers CD45RO, CD45RA, and CD27 identified distinct subsets of antigen-specific cells and the preferential loss of CD27(+) CD45RO(+) cells during periods of rapid decline in the frequency of tetramer-binding cells. In addition we were unable to confirm previous studies showing a consistent selective loss of HIV-specific cells in the context of sustained Epstein-Barr virus-specific cell frequencies. Overall, these data support a role of HIV-specific CTL in the control of disease progression and suggest that the ultimate loss of such CTL may be preferentially from the CD27(+) CD45RO(+) subset.

Use this form to to view general information about a study.
  • click on 'authors' to view the list of authors who contributed
  • click on 'files' to view a list of files, associated with this study: these files can be of any type: f.i. the full text of the article, or code used in the analysis, or a Powerpoint demonstration.
  • click on 'tables' to view a list of the database tables that were used in this study: more is information on these tables is available.
  • for studies related to the Amsterdam Cohort, the option 'progress' is available: it gives information about the process of collecting information about a study: who was asked for information, when was this done, is the information complete, etc.
  • if you have the authority to change data about the study, the option 'edit' is available: clicking this will take you to a form for editing the main information, with options to edit all aspects.
  • clicking on the PubMedID opens a new browser window with PubMed
  • clicking on the 'resp. centre' gives a list of all studies for this centre
  • click the 'back' button to go to the previous document